DK1379273T3 - Nukleinsyreadjuvanser - Google Patents
NukleinsyreadjuvanserInfo
- Publication number
- DK1379273T3 DK1379273T3 DK01274277T DK01274277T DK1379273T3 DK 1379273 T3 DK1379273 T3 DK 1379273T3 DK 01274277 T DK01274277 T DK 01274277T DK 01274277 T DK01274277 T DK 01274277T DK 1379273 T3 DK1379273 T3 DK 1379273T3
- Authority
- DK
- Denmark
- Prior art keywords
- nucleic acid
- molecules
- truncated
- acid adjuvants
- coding region
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 6
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 239000002671 adjuvant Substances 0.000 title 1
- 108091026890 Coding region Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000002095 exotoxin Substances 0.000 abstract 1
- 231100000776 exotoxin Toxicity 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72431500A | 2000-11-27 | 2000-11-27 | |
| PCT/US2001/043151 WO2003004055A2 (en) | 2000-11-27 | 2001-11-26 | Nucleic acid adjuvants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1379273T3 true DK1379273T3 (da) | 2009-11-09 |
Family
ID=24909936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01274277T DK1379273T3 (da) | 2000-11-27 | 2001-11-26 | Nukleinsyreadjuvanser |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1379273B1 (da) |
| JP (1) | JP4221289B2 (da) |
| KR (1) | KR20040045391A (da) |
| CN (1) | CN1317034C (da) |
| AT (1) | ATE442858T1 (da) |
| AU (1) | AU2001297988B2 (da) |
| BR (1) | BR0115646A (da) |
| CA (1) | CA2429708A1 (da) |
| DE (1) | DE60139959D1 (da) |
| DK (1) | DK1379273T3 (da) |
| ES (1) | ES2332261T3 (da) |
| IL (2) | IL156041A0 (da) |
| MX (1) | MXPA03004638A (da) |
| NZ (1) | NZ526175A (da) |
| PT (1) | PT1379273E (da) |
| WO (1) | WO2003004055A2 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1685251E (pt) | 2003-10-10 | 2014-04-15 | Powderject Vaccines Inc | Construções de ácido nucleico |
| CA2555013C (en) | 2004-02-11 | 2013-10-15 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Carcinoembryonic antigen fusions and uses thereof |
| GB0507997D0 (en) * | 2005-02-01 | 2005-05-25 | Powderject Vaccines Inc | Nucleic acid constructs |
| US8389686B2 (en) | 2008-05-07 | 2013-03-05 | Osaka University | Noncovalent collagen crosslinking agent |
| US11246915B2 (en) | 2010-09-15 | 2022-02-15 | Applied Molecular Transport Inc. | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo |
| RU2593715C2 (ru) | 2010-09-15 | 2016-08-10 | Рэндэлл Дж. МРСНИ | Системы и способы доставки биоактивных средств с применением транспортных последовательностей, происходящих от бактериального токсина |
| CN103060253A (zh) * | 2013-01-24 | 2013-04-24 | 麻丽丹 | 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用 |
| CN106470707A (zh) | 2014-05-07 | 2017-03-01 | 应用分子运输有限责任公司 | 用于口服递送生物活性货物的cholix毒素衍生的融合分子 |
| CN121513216A (zh) | 2018-03-08 | 2026-02-13 | 应用分子转运公司 | 用于经口递送的毒素衍生的递送构建体 |
| EP4083058A3 (en) | 2018-11-07 | 2023-01-11 | Applied Molecular Transport Inc. | Delivery constructs for transcytosis and related methods |
| MX2022001975A (es) | 2019-08-16 | 2022-03-11 | Applied Molecular Transport Inc | Composiciones, formulaciones y produccion y purificacion de interleucinas. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| TW360548B (en) | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
| GB9416663D0 (en) | 1994-08-17 | 1994-10-12 | Oxford Bioscience Limited | Particle delivery |
| EP0788386B1 (en) | 1994-10-24 | 1999-01-13 | PowderJect Research Limited | Needleless syringe |
| GB9426379D0 (en) | 1994-12-23 | 1995-03-01 | Oxford Biosciences Ltd | Particle delivery |
| US6056960A (en) * | 1995-06-07 | 2000-05-02 | Kaslow; Harvey R. | Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof |
| GB9612629D0 (en) | 1996-06-17 | 1996-08-21 | Oxford Biosciences Ltd | Method for providing dense particle compositions for use in transdermal particle delivery |
| US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
-
2001
- 2001-11-26 DK DK01274277T patent/DK1379273T3/da active
- 2001-11-26 AU AU2001297988A patent/AU2001297988B2/en not_active Ceased
- 2001-11-26 CA CA002429708A patent/CA2429708A1/en not_active Abandoned
- 2001-11-26 PT PT01274277T patent/PT1379273E/pt unknown
- 2001-11-26 EP EP01274277A patent/EP1379273B1/en not_active Expired - Lifetime
- 2001-11-26 AT AT01274277T patent/ATE442858T1/de active
- 2001-11-26 NZ NZ526175A patent/NZ526175A/en unknown
- 2001-11-26 MX MXPA03004638A patent/MXPA03004638A/es active IP Right Grant
- 2001-11-26 ES ES01274277T patent/ES2332261T3/es not_active Expired - Lifetime
- 2001-11-26 JP JP2003510065A patent/JP4221289B2/ja not_active Expired - Fee Related
- 2001-11-26 BR BR0115646-2A patent/BR0115646A/pt not_active Application Discontinuation
- 2001-11-26 CN CNB018195709A patent/CN1317034C/zh not_active Expired - Fee Related
- 2001-11-26 IL IL15604101A patent/IL156041A0/xx unknown
- 2001-11-26 KR KR10-2003-7007121A patent/KR20040045391A/ko not_active Ceased
- 2001-11-26 WO PCT/US2001/043151 patent/WO2003004055A2/en not_active Ceased
- 2001-11-26 DE DE60139959T patent/DE60139959D1/de not_active Expired - Lifetime
-
2003
- 2003-05-21 IL IL156041A patent/IL156041A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL156041A0 (en) | 2003-12-23 |
| PT1379273E (pt) | 2009-11-27 |
| MXPA03004638A (es) | 2004-04-20 |
| ATE442858T1 (de) | 2009-10-15 |
| EP1379273A2 (en) | 2004-01-14 |
| KR20040045391A (ko) | 2004-06-01 |
| WO2003004055A3 (en) | 2003-11-20 |
| AU2001297988B2 (en) | 2006-10-26 |
| EP1379273B1 (en) | 2009-09-16 |
| BR0115646A (pt) | 2005-12-13 |
| ES2332261T3 (es) | 2010-02-01 |
| DE60139959D1 (de) | 2009-10-29 |
| IL156041A (en) | 2010-05-17 |
| NZ526175A (en) | 2006-01-27 |
| WO2003004055A2 (en) | 2003-01-16 |
| JP2004536107A (ja) | 2004-12-02 |
| JP4221289B2 (ja) | 2009-02-12 |
| CN1317034C (zh) | 2007-05-23 |
| CN1537013A (zh) | 2004-10-13 |
| CA2429708A1 (en) | 2003-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110982T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων | |
| ATE491471T1 (de) | Adjuvantien für dns impstoffe basierend auf imidazochinoline | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| CY1118443T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| ATE181572T1 (de) | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe | |
| DK1203817T3 (da) | Forbindelser og fremgangsmåder til immunterapi og diagnose af tuberkulose | |
| DK1185691T3 (da) | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf | |
| DK1187591T3 (da) | IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme | |
| ATE442858T1 (de) | Nukleinsäureadjuvantien | |
| WO2003085085A3 (en) | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen | |
| ES2152251T3 (es) | Variantes del dominio lectina de la selectina. | |
| DK1379550T3 (da) | Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser | |
| DE60226175D1 (de) | Mycobakterieller impfstoff | |
| DK1119630T3 (da) | Nukleinsyrekonstruktioner til genetisk immunisering | |
| DK0575497T3 (da) | DNA-sekvenser, som koder for viruskarakteristika af Streptococcus suis og dele deraf, polypeptider og antistoffer afledt deraf og anvendelse deraf til diagnose af og beskyttelse mod infektion med S. suis i pattedyr, herunder mennesker | |
| DK0914437T3 (da) | Identificering og kloning af et mykobakterieantigen svarende til et heparinbindende hæmagglutinin | |
| DK1279677T3 (da) | GD3-mimetiske peptider | |
| DE60025704D1 (de) | Das goodpasture-antigen bindende protein | |
| DK0811071T3 (da) | Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner | |
| DE69840326D1 (de) | Steigerung der immunantwort unter verwendung von zielgerichteten molekülen | |
| WO2000063385A3 (en) | Nucleic acid immunization | |
| MXPA03010527A (es) | Composicion de vacuna. | |
| DE60229966D1 (de) | Diabetesmodell | |
| WO2002077648A3 (en) | Pathogenic and commensal vaccine antigens | |
| ATE355077T1 (de) | Verwendung von peptidvektoren zur verbesserung der immunantwort gegen antigene |